Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Income Tax department has completed the regular assessment under Section 143(3) and passed assessment order pertaining to AY ...

Mounjaro’s entry could see treatment for millions significantly change. “Mounjaro copies two significant hormones: Glucagon-like peptide-1 (GLP-1) and Gastric inhibitory polypeptide (GIP),” Dr.